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Abstract Macrocerebellum is a rare finding characterized by
an abnormally large cerebellum. Only few patients with a
syndromal or isolated macrocerebellum have been reported
so far. This article aims to categorize the magnetic resonance
imaging (MRI) findings, quantitate the macrocerebellum by
volumetric analysis, characterize the neurological and dys-
morphic features and cognitive outcome, and report the results
of genetic analyses in children with macrocerebellum. All MR
images were qualitatively evaluated for infratentorial and
supratentorial abnormalities. Volumetric analysis was per-
formed. Data about neurological and dysmorphic features,
outcome, and genetic analysis were collected from clinical
histories and follow-up examinations. Five patients were in-
cluded. Volumetric analysis in three patients confirmed large
cerebellar size compared to age-matched controls. MR evalu-
ation showed that thickening of the cortical gray matter of the
cerebellar hemispheres is responsible for the macrocerebel-
lum. Additional infratentorial and supratentorial abnormalities
were present in all patients. Muscular hypotonia, as well as
impaired motor and cognitive development, was found in all
patients, with ocular movement disorders in three of five
patients. The five patients differed significantly in terms of
dysmorphic features and involvement of extracerebral organs.
Submicroscopic chromosomal aberrations were found in two
A. Poretti : S. P. Toelle : E. Boltshauser (*)
Department of Pediatric Neurology,
University Children’s Hospital of Zurich,
Steinwiesstrasse 75,
8032, Zurich, Switzerland
e-mail: Eugen.Boltshauser@kispi.uzh.ch
A. Poretti : J. E. Benson :A. Meoded : T. A. G. M. Huisman
Division of Pediatric Radiology, Russell H. Morgan Department of
Radiology and Radiological Science,
The Johns Hopkins University School of Medicine,
Baltimore, MD, USA
V. Mall :N. H. Jung
Division of Neuropediatrics and Muscular Disorders,
Department of Pediatrics and Adolescent Medicine,
University Hospital Freiburg,
Freiburg, Germany
V. Mall :M. Smitka
Department of Pediatric Neurology, Pediatrics,
University Children’s Hospital Carl Gustav Carus,
Dresden University of Technology,
Dresden, Germany
S. Grunt :M. Steinlin
Department of Pediatric Neurology,
University Children’s Hospital of Bern,
Bern, Switzerland
S. Risen
Kennedy Krieger Institute,
Baltimore, MD, USA
S. Yoshida
Laboratory of Brain Anatomical MRI,
Russell H. Morgan Department of Radiology and Radiological
Science, The Johns Hopkins School of Medicine,
Baltimore, MD, USA
S. Tinschert : T. M. Neuhann
Institute of Clinical Genetics,
Medical Faculty Carl Gustav Carus,
Dresden University of Technology,
Dresden, Germany
A. Rauch
Institute of Medical Genetics, University of Zurich,
Zurich, Switzerland
Cerebellum (2012) 11:1026–1036
DOI 10.1007/s12311-012-0379-1
patients. Macrocerebellum is caused by thickening of the
cortical gray matter of the cerebellar hemispheres, suggesting
that cerebellar granule cells may be involved in its develop-
ment. Patients with macrocerebellum show highly heteroge-
neous neuroimaging, clinical, and genetic findings,
suggesting that macrocerebellum is not a nosological entity,
but instead represents the structural manifestation of a deeper,
more basic biological disturbance common to heterogeneous
disorders.
Keywords Cerebellum .Macrocerebellum . Neuroimaging .
Cognitive functions
Introduction
Macrocerebellum is a very rare finding and is characterized
by an abnormally large cerebellum with preservation of its
overall shape [1]. Its pathogenesis is unknown. Macrocer-
ebellum may be part of a well-defined syndromal condition
as Sotos syndrome [2], Costello syndrome [3], Williams
syndrome [4], macrocephaly-capillary malformation syn-
drome [5, 6], Alexander disease [7, 8], fucosidosis [9], or
Lhermitte–Duclos syndrome (Table 1) [10–12]. Additional-
ly, patients with isolated (nonsyndromal) macrocerebellum
have also been reported [13, 14].
This article aims to (1) characterize the neurological and
dysmorphic features as well as the neurodevelopmental
outcome, (2) evaluate the spectrum of neuroimaging find-
ings, (3) quantitatively verify the qualitative evaluation of
an increased cerebellar volume, and (4) present the results of
genetic investigations in our cohort of patients with a
macrocerebellum.
Patients and Methods
Patient Cohort
The patients included in this study were found by the senior
author (EB) from three sources: (1) his personal database of
patients with cerebellar abnormalities, (2) neuroimaging
data of referred patients subsequently diagnosed with mac-
rocerebellum, and (3) personal contacts with other clinical
professionals who contributed cases. The inclusion criterion
for this retrospective study was a qualitatively large cere-
bellum on MR images in midsagittal (large cerebellar ver-
mis filling the posterior fossa with absence or decrease of
the physiological retrovermian amount of cerebrospinal flu-
id (CSF)) or axial (large cerebellum filling the posterior
fossa with absence or decrease of the physiological pericer-
ebellar/retrocerebellar amount of CSF) planes.
Clinical Analysis
Review of the clinical histories and clinical–neurological
follow-up examinations provided detailed information
about neurological and dysmorphic features as well as
neurodevelopmental outcome. These details are listed in
Table 2.
Qualitative Neuroimaging Analysis
In a retrospective fashion, two pediatric neurologists with
experience in neuroimaging of the pediatric cerebellum (AP
and EB) qualitatively analyzed all available imaging data
sets. The parameters chosen for evaluation are listed in
Table 3.
Table 1 Differential diagnosis of macrocerebellum
Disease OMIM Additional neuroimaging findings References
Sotos syndrome #117550 Ventricular abnormalities, increased extracerebral fluid spaces,
midline abnormalities, and migration anomalies
[2]
Costello syndrome #218040 Macrocerebellum progressively causing cerebellar tonsillar
herniation and hydrocephalus, Chiari 1, syrinx formation
[3]
Williams syndrome #194050 “Small cerebrum” [4]
Macrocephaly-capillary malformation %602501 Hydrocephalus, asymmetric lateral ventricle, white matter defects,
hemimegalencephaly, Chiari 1, polymicrogyria, cortical dysplasia
[5, 6]
Alexander disease #203450 Symmetrical cerebral white matter abnormalities with a frontal
preponderance, periventricular rim of decreased signal intensity
on T2-weighted images, abnormalities of the basal ganglia,
thalami, and brainstem, contrast enhancement involving several
brain structures
[7, 8]
Fucosidosis #230000 Hypomyelination and T1-weighted hyperintensity of putamina and
globi pallidi
[9]
Lhermitte–Duclos syndrome #158350 Non-enhancing gyriform pattern, hypointensity on T1-weighted
images, striated pattern with isointense bands in the area of
hyperintensity on T2-weighted images
[10–12]
Modified with permission from Poretti and Boltshauser [1]
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Volumetric Analysis
Volumetric analysis was performed using axial and sagittal
3D T1-weighted images. These were available for three
patients. Five age- and gender-matched Caucasian controls
were selected for every patient from the pediatric MR data-
base at Johns Hopkins Hospital using the following criteria:
(1) normal brain anatomy, (2) absence of neurological dis-
orders, and (3) availability of 3D T1-weighted images. We
decided not to use control data about the cerebellar volume
from the literature [9, 15] because of different post-
processing methods. For the off-line post-processing, we
used DtiStudio, DiffeoMap, and RoiEditor software (H.
Jiang and S. Mori, Johns Hopkins University, available at
http://www.MriStudio.org) as well as FSL software (The
University of Oxford, available at http://www.fmrib.ox.
ac.uk). The post-processing was performed by AP and SY.
First, atlas-based normalization was performed for the
images of control 3 to create a template with structural
parcellation for this study. This control was chosen because
the age corresponded most closely to the JHU-DTI-MNI
“Eve” template (a single-subject template in the ICBM-
DTI-81 space that is extensively parcellated and labeled into
130 structures). After skull-stripping using RoiEditor and
FSL, the images were first normalized to the “Eve” template
with a nine-parameter affine linear transformation. Subse-
quently, a nonlinear transformation using single-contrast
(T1-weighted images) large deformation diffeomorphic met-
ric mapping was applied [16]. Because both linear and
nonlinear transformations are reciprocal procedures, the in-
versely transformed brain parcellation map was superimpos-
able onto the original 3D T1-weighted images from control
3, leading to the parcellation of the brain into 130 anatom-
ical structures.
Next, for the 3D T1-weighted images of the other con-
trols and patients, we performed the same atlas-based trans-
formation using the image of control 3 as the template,
followed by minimum manual adjustment. As a result, the
quantitative volume values (number of voxels) for 130
parcellated brain structures were obtained for each patient
and control.
Among 130 parcellated brain structures, the total number
of voxels of the cerebellar regions (region no. 28, “cerebel-
lum left”; region no. 50, “middle cerebellar peduncles left”;
region no. 93, “cerebellum right”; region no. 115, “middle
cerebellar peduncles right”) was used to calculate the cere-
bellar volume. The right half of the cerebellar vermis is
included within the region “cerebellum right” and the left
one within the region “cerebellum left.” The middle cere-
bellar peduncles were included into the volume calculation
because they are a significant part of the cerebellar volume.
Because every voxel measures 1×1×1 mm, the cerebellar
volume was measured in cubic millimeters.
Genetic Studies
Genetic analyses included (1) cytogenetic karyotyping of
metaphases from peripheral blood lymphocytes by GTG
banding analysis, (2) molecular karyotyping by single nu-
cleotide polymorphism (SNP) array with an Affymetrix
100 K Nsp Gene Chip Array (patient 1) and Illumina Hu-
man Quad 610 BeadChip containing 610,000 SNPs (patient
5) and by high-resolution oligonucleotide array comparative
genomic hybridization (CGH) analysis with a Roche Nim-
blegen Human CGH Microarray Kit 135 (patient 2), Blue-
Gnome Human CGH Microarray Cytochip v1.0 Kit 180
(patient 3), and Agilent’s Human CGH Microarray Kit
244A (patient 4), and (3) mutation analysis for selected
genes (patients 1 and 3).
Results
Patient Characteristics
Five Caucasian patients were included in this study. At the
last follow-up, the median age was 33 months (mean,
27 months; range, 12 to 37 months). The patient character-
istics are included in Table 2. Clinical and genetic findings
of patient 4 were included in a previous report [17].
Clinical Findings
The clinical, neurological, and dysmorphic characteristics of
the five patients with macrocerebellum are summarized in
Table 2. Ataxia could not be evaluated for patients 2, 3, and
5 because of the developmental age.
Detailed data on motor and/or cognitive development
were abnormal in all patients. At the age of 36 months,
patient 1 was able to roll over serially and grasp at toys
(and throw them away immediately), but was not able to
feed himself. He understood a few simple tasks and had no
speech, though showed his agreement/refusal by head
movements. The estimated developmental age was 9 months
(corresponding to a developmental quotient (DQ) of 25).
The DQ of patient 2, measured at the age of 18 months with
the Griffiths Mental Developmental Scale, was 69
(corresponding to a developmental age of 12.4 months).
His motor abilities corresponded to a developmental age of
7 months (rolling over serially, but not able to sit). His
hearing and speech ability corresponded to 12 months, his
performance ability to 12.5 months, eye–hand coordination
ability to 13.5 months, and personal–social ability to
14 months. At the age of 18 months, patient 3 appeared
interested and active. She spoke only about 10 words, was
able to grasp at toys, stand up, and walk around, though only
with support. The estimated developmental age was
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14 months (corresponding to a DQ of 77). At the age of
20 months, patient 4 was not able to stand or fix his gaze on
an object and follow it, but could produce a few incompre-
hensible sounds. During further follow-up, patient 4 did not
achieve new significant developmental milestones. The es-
timated developmental age was 3 months (corresponding to
a DQ of 8). Finally, the DQ of patient 5 was measured at the
corrected age of 5 months with the Clinical Adaptive Test
and the Clinical Linguistic and Auditory Milestone Scale:
the DQ for the cognitive portion was 92 (corresponding to a
developmental age of 4.6 months), while the DQ for lan-
guage was 86 (corresponding to a developmental age of
4.3 months). At the corrected age of 12 months, she was
able to sit briefly, but not able to get to sitting position
without assistance, crawl forward, or stand momentarily
without support. She used pincer grasp, was able to ex-
change objects, and said “mama” and “dada.” The achieved
developmental milestones suggest a mild developmental
delay, but the child is still very young for a conclusive
evaluation.
Qualitative Neuroimaging Findings
Results of the qualitative neuroimaging analysis of each
patient’s most recent magnetic resonance imaging (MRI)
(median age, 14 months; mean, 15 months; range, 7 to
27 months) are summarized in Table 3 and shown in Figs. 1,
2, 3, 4, and 5. Patients 3 and 5 had hydrocephalus: in patient
5, Sylvian aqueduct occlusion (not secondary to compres-
sion by the macrocerebellum) was the most likely cause,
whereas in patient 3, the etiology was postulated to be
macrocerebellum (obstructing the CSF circulation at the
level of the posterior fossa) and/or herniation of the cerebel-
lar tonsils. Additionally, in patient 5, the corpus callosum
was very thin in its posterior part and the most anterior part
appeared underdeveloped.
For patients 2, 3, and 5 additional prior MR images at the
age of 12 months; 8, 11, and 17 months; and 2 days, re-
spectively, were available. In all patients, the cerebellar
findings were consistent on the follow-up images. Addition-
ally, in patient 2, myelination of the white matter slightly
improved. In patient 3, ventriculomegaly and diffuse, supra-
tentorial T2 hyperintense signal abnormalities of the white
matter were stable. In patient 5, the size of the lateral
ventricles decreased significantly after placement of a ven-
triculoperitoneal shunt.
Volumetric Findings
Volumetric analysis was performed in three patients (patients
1–3; mean age, 9.6 months; median age, 11 months) and 15
age- and gender-matched controls (mean age, 9.6 months;
median age, 11 months). In patient 4, volumetric analysis
could not be performed because 3D T1-weighted images
were not available; in patient 5, susceptibility artifacts
related to the ventriculoperitoneal shunt degraded the
images. The results are shown in Table 4. The mean cere-
bellar volume for controls 1a–e is 68,670 (SD, 2,278), for
controls 2a–e is 102,777 (SD, 1,578), and for controls 3a–e
is 97,271 (SD, 1,917). The ratio between the sum of the
cerebellar volumes of the patients and the sum of the mean
cerebellar volumes of the three control groups is 1.49. No
statistical analysis was performed because of the small
number of patients and controls.
Genetic Findings
Cytogenetic karyotyping at 400–550 band resolutions (ISCN
2009) was normal in all patients. Molecular karyotyping was
normal in patients 1, 2, and 3, but revealed compound hetero-
zygosity for a recurrent 1.5-Mb deletion within chromosome
15q13.3 and a 3.4-Mb deletion in 15q13.1–q13.3, resulting in
Fig. 1 Midsagittal (a), coronal (b), and axial (c) T2-weighted MR
images of patient 1 at the age of 7 months show macrocerebellum with
marked thickening of the cerebellar gray matter, but a mild volume
decrease of the cerebellar white matter. Additional abnormalities illus-
trated: mild cerebellar dysplasia involving the posterior part of the
hemispheres (c), an elongated and thickened mesencephalon (a), a
short pons (a), a wide prepontine cistern (a), and a moderate ventricu-
lomegaly (b). Reprinted with permission from Poretti and Boltshauser
[1]
Cerebellum (2012) 11:1026–1036 1031
homozygous loss of the CHRNA7 gene in patient 4 [6], and a
1.2-Mb heterozygous duplication on chromosome 1q42.3–
q43 extending from 234,006,469 to 235,244,194 on build
HG18 or NCBI36 in patient 5. Mutations could not be found
within the MECP2, CDKL5, ARX, NTNG1, and PHF6 genes
in patient 1 or the NSD1 gene in patient 3. Patient 5 has a
healthy identical twin, but molecular cytogenetic analysis is
not available for the twin and parents.
Discussion
A “small”, hypoplastic cerebellum is not an unusual finding in
pediatric neuroimaging. Reports suggest etiologies including
prenatal infections, prenatal teratogen exposure, chromosomal
aberrations, metabolic disorders and genetic (isolated or com-
plex) brain malformations including migration disorders,
some forms of congenital muscular dystrophies, and ponto-
cerebellar hypoplasia [18]. A “large” cerebellum, on the other
hand, is a very rare finding and has been inconsistently
reported in few syndromes (Table 1) [3–12]. In all these
syndromes, macrocerebellum is associated with additional
characteristic clinical and/or neuroimaging findings which
usually lead to the correct diagnosis. None of the patients
included in our cohort, however, matched the characteristic
clinical and neuroimaging findings of the syndromal condi-
tions reported above.
Beyond these syndromes, macrocerebellum has been
reported in only one additional patient cohort and in a single
case (Table 5). Bodensteiner et al. reported four patients
(age range, 9 months to 2 years) presenting with global
developmental delay, muscular hypotonia, and ocular motor
apraxia [13]. Additionally, deficient or delayed myelination
of cerebral white matter was found in all patients. Picchiec-
chio et al. reported about a 19-month-old child with agenesis
of the corpus callosum, who showed progressive enlarge-
ment of the cerebellum on sequential imaging studies [14].
The clinical examination revealed microcephaly, strabismus,
global muscular hypertonia, developmental delay (DQ of
50), and dysmorphic features.
Fig. 2 Midsagittal (a) and axial
(b) T2-weighted MR images of
patient 2 at the age of 11 months
show macrocerebellum with a
marked thickening of the cere-
bellar gray matter (b), but a nor-
mal amount of cerebellar white
matter (not shown). Additional-
ly, size reduction and upward
displacement of the fourth ven-
tricle (a), premesencephalic het-
erotopia (white arrows in a), an
arachnoid cyst in the left cere-
bellopontine angle (black aster-
isk in b), and a flat sella (white
arrowheads in a) are noted
Fig. 3 Midsagittal (a) and axial (b) T2-weighted MR images of patient
3 at the age of 8 months show macrocerebellum with a marked
thickening of the cerebellar gray matter, a size reduction of the fourth
ventricle, a downward herniation of the cerebellar tonsils (white arrow
in a), a narrow prepontine cistern, and a thickened mesencephalon. A
supratentorial axial T2-weighted image (c) shows diffuse T2 hyperin-
tense signal abnormality of the periventricular white matter is noted.
Additionally, notice the patent Sylvian aqueduct (a) and the ventricular
catheter of the ventriculoperitoneal shunt (white arrow in c)
1032 Cerebellum (2012) 11:1026–1036
The majority of our patients presented during the neona-
tal period because of different problems including macro-
cephaly, hydrocephalus, or respiratory distress. The patient
reported by Picchiecchio et al. presented also at birth be-
cause of craniofacial dysmorphic features [14].The patients
of Bodensteiner et al., on the other hand, were slightly older
(9 months to 2 years) and with more homogenous symptoms
and findings [13]. At the last follow-up, all of our patients
had muscular hypotonia, whereas ocular movement disor-
ders, ataxia, and epilepsy were less common findings. Pic-
chiecchio et al. reported global muscular hypertonia in their
patient, but no epileptic seizures or ocular movement disor-
ders [14], whereas all patients of Bodensteiner et al. had
muscular hypotonia, decreased coordination, and ocular
movement disorders, but no epileptic seizures [13]. Muscu-
lar hypotonia and ocular movement disorders are present
in the majority of the patients and could represent the
neurological presentation of children with a macrocerebel-
lum. These neurological signs are, however, highly nonspe-
cific and may be found in many other pediatric neurological
disorders.
All our patients, as well as those reported by Boden-
steiner et al. and Picchiecchio et al., have some degree of
impairment in motor and cognitive development. It is well-
known that small or structurally abnormal cerebellum
results in motor and cognitive maldevelopment [19, 20].
Supratentorial abnormalities may also cause impairment of
motor and cognitive development. Implicating macrocere-
bellum alone as a cause of delay in the three study cohorts is
difficult because of the frequency of supratentorial abnor-
malities in these patients. However, the role of macrocer-
ebellum cannot be discounted and could well have a
negative effect comparable that of the other known structur-
al cerebellar and supratentorial abnormalities. Of course, the
Fig. 4 Midsagittal (a) and axial (b) T2-weighted MR images of patient
4 at the age of 10 months show a macrocerebellum with a marked
increase of the cerebellar gray matter. Additionally, a size reduction of
the fourth ventricle (a), a right paracerebellar arachnoid cyst (black
asterisk in b), and a thin corpus callosum (a) are noted. On the supra-
tentorial axial T2-weighted image (c), a marked and diffuse volume
loss of the white matter is noted
Fig. 5 Midsagittal (a), coronal (b), and axial (c) T2-weighted MR
images of patient 5 at the age of 12 months show a macrocerebellum
with a marked increase of the cerebellar gray matter (c). Additional
abnormalities: mild upward displacement of the fourth ventricle (a), an
upward herniation of the vermis and paravermian cerebellar tissue
through the tentorium (black arrows in b), wrapping of the cerebellar
hemispheres around the brainstem (c), a “beak-like” appearance of the
tectum (a), a narrow prepontine cistern (a), a thin and dysplastic corpus
callosum (a), and absence of the septum pellucidum (b). The Sylvian
aqueduct is occluded (a). Imaging of the right cerebellar hemisphere is
markedly disturbed by susceptibility artifacts related to the ventriculo-
peritoneal shunt
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follow-up time is short and the patients were very young at
the time of assessment.
Four of our patients had a variety of dysmorphic signs
and two had involvement of extracerebral organs. The pa-
tient of Picchiecchio et al. as well as those of Bodensteiner
et al. showed craniofacial dysmorphic signs, but no involve-
ment of extracerebral organs [13, 14]. Thus, a specific
pattern of craniofacial dysmorphic features or other malfor-
mations predicting macrocerebellum does not appear to be
present.
The pathogenesis of macrocerebellum is still unknown.
The qualitative evaluation of our patients with macrocere-
bellum showed that the large cerebellar size is caused by
enlargement of the cerebellar hemispheres rather than of the
cerebellar vermis. In one patient, we even found hypoplasia
of the inferior vermis. Matching our observation, Boden-
steiner et al. did not find a statistically significant difference
between patients and controls when comparing two-
dimensional morphometric measurement of the vermis
[13]. This suggests that the vermis might be less affected
by the process leading to a macrocerebellum. Interestingly,
the posterior fossa never shows compensatory enlargement.
Rather, the cerebellar hemispheres expand into adjacent
anatomical regions by wrapping around the brainstem and
herniating upward or downward.
In our patients, qualitative evaluation of cerebellar archi-
tecture revealed that the large size of the cerebellar hemi-
spheres is caused by thickening of the cerebellar gray
matter, while the volume of the cerebellar white matter
appears normal or even reduced. The other two publica-
tions did not report this observation, and review of their
published images does not suggest that this is present
[13, 14]. Figures 1, 2, 3, 4, and 5 conversely show a
striking imbalance in the normal proportions of gray to
white matter. Why this was not a feature of the other two
study cohorts is unknown, but this might point to a bio-
logic avenue of investigation.
Cerebellar granule cells are one of the two main cellular
populations in the cortical cerebellar gray matter [21]. Inacti-
vation of Pten in specific mouse neuronal populations results
in progressive increase in size of the granule cells, giving
cerebellar abnormalities closely resembling the histopatholo-
gy of human Lhermitte–Duclos syndrome [22, 23]. Lher-
mitte–Duclos syndrome is characterized by hypertrophy of
the cerebellar cortex [10–12]. Though this hypertrophy is
focal, not the global thickening seen in the present study
group, it is still an intriguing example of this histopathologic
mechanism. Genes encoding direct regulators of the cell cycle
are critical for proper proliferation of granule cells [24].Cyclin
D2 is a positive regulator of the cell cycle. Its inactivation in
mice causes reduction of the granule cell population because
of decreased proliferation and increased apoptosis of granule
progenitors and results in cerebellar hypoplasia [25]. On the
other hand, inactivation of p27Kip1, a negative regulator of
the cell cycle, results in an increased proliferation of granule
cells and formation of a large cerebellum [26]. Additional
Table 4 Results of cerebellar
volumetric studies in three
patients with macrocerebellum
and age- and gender-matched
controls
MCP middle cerebellar
peduncles
Gender Age at MRI
(months)
Volume (mm3)
Cerebellum
left
Cerebellum
right
MCP left MCP right Total
Patient 1 Male 7 44,631 45,067 2,746 3,016 95,460
Patient 2 Male 11 60,626 58,162 5,080 5,789 129,657
Patient 3 Female 11 82,245 84,596 5,416 5,123 177,380
Control 1a Male 7 32,926 33,010 2,110 2,099 70,146
Control 1b Male 7 30,371 32,153 2,174 2,194 66,891
Control 1c Male 7 31,362 31,307 2,058 2,183 66,910
Control 1d Male 7 31,524 31,822 2,098 1,998 67,443
Control 1e Male 7 33,504 34,191 2,122 2,142 71,959
Control 2a Male 11 47,961 46,688 4,298 4,362 103,309
Control 2b Male 11 46,062 47,091 4,241 4,265 101,658
Control 2c Male 11 48,768 47,899 4,337 4,286 105,291
Control 2d Male 11 46,908 46,438 4,068 4,051 101,465
Control 2e Male 11 47,288 46,575 4,181 4,116 102,160
Control 3a Female 11 43,235 45,004 3,664 4,240 96,143
Control 3b Female 11 44,310 46,306 3,579 4,025 98,221
Control 3c Female 11 43,675 44,269 3,990 3,431 95,365
Control 3d Female 11 45,813 43,759 3,493 3,416 96,480
Control 3e Female 11 47,326 45,876 3,340 3,605 100,147
1034 Cerebellum (2012) 11:1026–1036
genes, as well as environmental substances, may also play a
role in regulating cell number or influencing neurogenesis and
gliogenesis in the embryonic and postnatal brain, but their
involvement in the pathogenesis of macrocerebellum has not
been demonstrated so far [18].
Molecular cytogenetic studies revealed submicroscopic
chromosomal anomalies in two patients of our cohort. The
compound heterozygous deletions on chromosome 15q13 in
patient 4 included a homozygously deleted segment in
15q13.3 that encompasses the CHRNA7 gene. Patients with
homozygous deletions of the CHRNA7 gene can present
with refractory epileptic seizures, cognitive impairment,
severe muscular hypotonia, autistic features, choreoathetotic
movements, and congenital retinal dysfunction [17, 27–29].
Neuroimaging findings in five additional patients with ho-
mozygous deletions of the CHRNA7 gene included multiple
arachnoid cysts in three patients and bilateral frontal volume
loss in two patients, while MRI was normal in one patient
[17, 27–29]. Heterozygous 15q13.3 microdeletions have been
identified as a predisposition to cognitive impairment, epilep-
sy, and psychiatric diseases [27]. The significance of the small
heterozygous duplication on chromosome 1q42.3–q43 in pa-
tient 5 remains unclear because molecular cytogenetic studies
are not available for the twin and parents. Macrocerebellum,
however, has not been described in patients with 15q13.3
microdeletions as well as submicroscopic chromosomal
anomalies on the long arm of chromosome 1. It is plausible
that macrocerebellummay be due not only to different expres-
sions of genetic aberrations, but also to disturbances at different
stages of cerebellar development. In patient 5, macrocerebellum
was present already at 2 days of age. In the patient reported by
Pichiecchio et al., however, cerebellar size was normal during
the neonatal period and macrocerebellum was detected first at
the age of 19 months [14].
We are aware of some limitations in our study. Although
this is the largest reported cohort, the number of patients with
macrocerebellum is still small. Additionally, the follow-up
time is short. Moreover, volumetric analysis was only per-
formed in three patients. Finally, the DQwas onlymeasured in
two patients using standardized developmental tests.
Conclusions
Macrocerebellum is a qualitatively recognizable finding on
neuroimaging and is quantitatively verifiable. Comparison
of these 10 cases points out the heterogeneous clinical and
imaging context in which it is seen. There is likely a biologic
explanation—possibly involving granule cell growth—that in
turn may link the disparate syndromes in which it is seen.
More patients need to be studied; it is hoped that this paper
will stimulate the search for these patients and facilitate rec-
ognition of macrocerebellum as a recordable diagnostic
observation.
Table 5 Clinical and neuroimaging characteristics in five published patients with macrocerebellum
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Author Bodensteiner [13] Bodensteiner Bodensteiner Bodensteiner Pichiecchio [14]
Gender Male Female Male Male Male
Age (months) 30 24 11 9 19
HC (head circumference) Normal Decreased Decreased Normal Decreased
Muscle tone Decreased Variable Decreased Decreased Increased
Ataxia No No No No n.a.
Ocular movement disorders OMA OMA Unknown OMA Left eye squint
Epilepsy No No No No No
Motor development delay ++ +++ + ++ DQ 50
Cognitive development delay ++ +++ ++ +++
Other neurological findings No Brisk reflexes No No Ptosis, poor facial
mimic, brisk
reflexes
Dysmorphic signs Yes Yes Yes No Yes
Vermis size Increased Normal Increased Increased Unknown
Cerebellar dysplasia No No No No No
Cerebellar white matter Normal Normal Normal Normal Normal
Supratentorial white matter Delayed myelination Delayed myelination Delayed myelination Delayed myelination Delayed myelination
Additional neuroimaging
findings
No No No No Corpus callosum
agenesis
DQ developmental quotient,MRI magnetic resonance imaging, n.a. not applicable, OMA ocular motor apraxia, + mild, ++ moderate, +++ marked
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